Horses help the disabled through therapeutic riding in Rhode Island
In Harmony Therapeutic Riding Inc. in Hopkinton, Rhode Island, uses hippotherapy and therapeutic riding to strengthen motor control, balance, and confidence for about 130 students with cerebral palsy, spina bifida, mental retardation, and other disabilities. Veterans, children, and adults ride under the care of trained instructors and a large volunteer network, while therapists note improvements in head and trunk balance and social skills. Insurance coverage for hippotherapy is often limited and handled case by case.
MENTIONED IN THIS ARTICLE
West
In Harmony Therapeutic Riding Inc
Silver Cascades
New Hampshire
Jonathan
Maria Blackstone
Barbara Poulin
Annie Grills
Annie
Windsor
Amy Maslyn
Maslyn
Europe
United States
Michael Kaufmann
Riding For the Handicapped Association
Kaufmann
North America
In Harmony
Rhode Island
New England
Hasbro Children’s Hospital
Providence
Ellen Sturtevant
Sturtevant
The
Health Insurance Association of America
Hopkinton
R.I. Grills
Shopping bots redefine themselves to stay viable
Online price comparison sites facing a shakeout shift toward partnerships and broader features. With few pure play bots remaining, leaders like Dealtime, Intellishop and mySimon expand services to compete with portals such as Yahoo Shopping and eBay.
MENTIONED IN THIS ARTICLE
New York
Bottomdollar.com
Brandwise.com
Dealtime.com
Intellashop.com
mySimon.com
Ken Cassar
Jupiter Research
Yahoo! Shopping
Sean Kaldor
Nielsen/NetRatings
eBay
Cassar
Ture
Copernic
Jupiter Media Metrix
BizRate.com
PriceGrabber.com
BizRate
Chuck Davis
Dot-coms shrink and refocus amid tough market
Nielsen NetRatings reports page visits down as sites trim content and push direct product access. PriceGrabber touts steady since 1999 launch by avoiding banners and using preferential search placement. Intellashop.com downsizes 45 percent. seeks partners with ebrick.com and talks with Excite.com to stay afloat.
MENTIONED IN THIS ARTICLE
Nielsen/NetRatings
PriceGrabber
Dan Goldman
Goto.com
Findwhat.com
Intellashop.com
Reggie Syed
Ebrick.com
Excite.com
Antibody Industry Recoils to Genomic Advances and New Drugs
The human genome map and a wave of new antibody drugs revive interest in monoclonal antibodies once shunned as costly and unreliable. Firms like Medarex, Genentech, Idec, and J&J push toward humanized mouse technologies, faster development, and broader pipelines while analysts forecast rising 2009 sales. experts caution antibodies alone won’t cure cancer.
MENTIONED IN THIS ARTICLE
AN Diego
Biotechnology
Walter Newman
Millennium Pharmaceuticals
Novartis Pharma AG
Health and Human Services
Tommy G. Thompson
Genentech Inc
Genentech
Idec Pharmaceuticals Corp
Johnson & Johnson
Wall Street
Fred Hutchinson Cancer Research Center
Christopher Widwell
American Cancer Society
Donald Drakeman
Medarex
Drakeman
Newman
England
Cesar Milstein
Georges Kohler
Abgenix Inc
Herman Kattlev
Also Mentioned on This Page
Davis
Half.com
My Simon
Cnet Networks Inc
Vince Broady
Nintendo
Broady
Dealtime
Aol.com
iWon.com
Deborah Sack
Mysimon